Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20266 Citations
BAM-15 is a selective mitochondrial uncoupler that reduced fat mass and improved insulin sensitivity in mice without raising body temperature. Oral and non-stimulant, it draws interest as a safer DNP alternative, though zero human trials exist and community doses fall far below allometric estimates.
200mcg · Daily
Summary: Add 0mL BAC water to your 250mg vial. Draw to < 0.1 units on a U-100 syringe for a 200mcg dose. This vial will last 0 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 200mg | Daily |
| Moderate | 400mg | Daily |
| Aggressive | 600mg | Daily |
BAM-15 is an oral small molecule. No reconstitution, no bacteriostatic water, no syringes. Buy it as powder or pre-made capsules. The short half-life (1.7 hours) means once-daily dosing is near-pointless. You need at least two doses per day spaced six hours apart. Three is better if you can manage it. Morning, early afternoon, and late afternoon with food works for most schedules. Skip the evening dose if it affects sleep. Powder sourcing matters here. Research-grade suppliers like Cayman Chemical or Sigma-Aldrich provide HPLC-verified material with proper CAS verification (210302-17-3). Gray-market capsule vendors don't offer the same quality accountability; dosing accuracy in DIY capsules is suspect because BAM-15 has low water solubility, making even powder distribution inside gelatin caps inconsistent. Store powder at negative 20 degrees Celsius, desiccated, away from light. If you dissolve it in DMSO for research use, that solution stays stable at negative 20 degrees Celsius for up to six months. Avoid repeated freeze-thaw cycles. The community dose range (50 to 300 mg per day) sits 5 to 30 times below what allometric scaling predicts as therapeutic. That might mean sub-therapeutic dosing or conservative safety reasoning. Nobody knows yet.
Dosing based on Dose extrapolated from mouse metabolic studies using allometric scaling; no human data — 9 published references.View all sources →
Cross-check your BAM-15 reconstitution math with AI
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
BAM-15 is a selective mitochondrial uncoupler that reduced fat mass and improved insulin sensitivity in mice without raising body temperature. Oral and non-stimulant, it draws interest as a safer DNP alternative, though zero human trials exist and community doses fall far below allometric estimates.